Mayo Clinic researchers have uncovered molecular signatures of blood-brain barrier dysfunction in DOI: 10.1038/s41467-024-48926-6
This research is part of a federal grant supporting projects that identify targets for Alzheimer’s disease treatment. The study was supported in part by the